RNS Number : 6285L
Osirium Technologies PLC
07 September 2023
 

The information contained within this announcement is deemed by Osirium to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended.

 

7 September 2023

 

Osirium Technologies plc

("Osirium" or the "Group")

 

Half Year Results and Bridge Finance Facility

 

Osirium Technologies plc (AIM: OSI), a leading vendor of cloud-based cybersecurity and IT automation software, announces its unaudited interim results for the six months ended 30 June 2023.

 

Financial highlights

 

·     

Annualised recurring revenue ("ARR") for June 2023 of £2.16 million, an increase of 34% from June 2022 (ARR: £1.61 million)

·     

Total bookings increased to £1.22 million (H1 2022: £1.18 million)

·     

Deferred revenue increased 50% to £2.87 million (H1 2022: £1.91 million)

·     

Operating loss reduced to £1.24 million (H1 2022: £1.63 million)

·     

Cash balance at 30 June 2023 of £0.22 million (30 June 2022: £0.27 million), and debtors at 30 June 2023 of £0.40 million (30 June 2022: £0.33 million)

 

Operational highlights

 

·     

Maintained average contract values

·     

New partner-first strategy underpinned customer acquisition, with 22 customers signed during the six-month period

·     

All three products successfully serving as first points of entry for new customers

·     

Significant number of expansions and renewals

·     

Core focus on customer success validated by Software Reviews: "Gold Medal" rating and number one ranking in vendor support received

                                                                   

Post period highlights

 

·     

As announced on 30 August 2023, agreement was reached with SailPoint Technologies UK Ltd for the recommended cash acquisition of the entire issued, and to be issued, ordinary share capital of Osirium

·     

£200,000 Bridge Finance Facility put in place with SailPoint Technologies UK Ltd to fund operating costs during the offer period of the acquisition

·     

The Group's network and strong reputation supporting further renewals and customer wins in H2 2023

 

 

Contacts:




Osirium Technologies plc

Tel: +44 (0)1183 242 444

Stuart McGregor, Chief Executive Officer


Rupert Hutton, Chief Financial Officer




Allenby Capital Limited (Nominated adviser and broker)

Tel: +44 (0)20 3328 5656

James Reeve / George Payne (Corporate Finance)


Tony Quirke / Stefano Aquilino (Sales and Corporate Broking)




Alma PR (Financial PR adviser)

Tel: +44 (0)20 3405 0205

Hilary Buchanan

osirium@almapr.co.uk

Kieran Breheny


Will Ellis Hancock


 

 

About Osirium Technologies Plc

 

Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity software vendor delivering Privileged Access Management (PAM), Privileged Endpoint Management (PEM) and Osirium Automation solutions that are uniquely simple to deploy and maintain.

 

With privileged credentials involved in over 80% of security breaches, customers rely on Osirium PAM's innovative technology to secure their critical infrastructure by controlling 3rd party access, protecting against insider threats, and demonstrating rigorous compliance. Osirium Automation delivers time and cost savings by automating complex, multi-system processes securely, allowing them to be delegated to Help Desk engineers or end-users and to free up specialist IT resources. The Osirium PEM solution balances security and productivity by removing risky local administrator rights from users, while at the same time allowing escalated privileges for specific applications.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to trading on AIM in April 2016. For further information please visit www.osirium.com.

 

 



 

Chief Executive Officer's Review

 

Proposed Acquisition of Osirium

 

As reported on 30 August 2023, the Board is pleased to announce an agreement with the Board of Directors of SailPoint Technologies UK Ltd ("BidCo"), which is indirectly owned by SailPoint Parent, L.P., for the recommended cash acquisition of the entire issued, and to be issued, ordinary share capital of Osirium (the "Acquisition"). Under the terms of the Acquisition, each Osirium Shareholder will be entitled to receive 2.35 pence in cash for each Osirium Share. The Acquisition values Osirium's entire issued, and to be issued, ordinary share capital at approximately £3.11 million on a fully diluted basis and implies an enterprise value of approximately £6.56 million.

 

The Board believes the Acquisition will provide the scale, recognition and resources that will enable the full potential of Osirium's PAM, EPM and PPA solutions.

 

Further, we believe that the Acquisition fairly recognises the medium-term prospects and growth potential of Osirium as a standalone business and provides Osirium Shareholders with an immediate and certain value in cash.

 

The proposed Acquisition is subject to shareholder approval at a court meeting and at a general meeting, the dates of which will be announced in due course.

 

HY23 performance

 

Overview

 

The Group is pleased to report a period of continued trading momentum, in which it has strengthened its presence in the public and private sectors alongside ensuring its offering remains a compelling option for customers through enhancements to its privileged security solutions. Alongside this trading performance, the Group has maintained a focus on managing its cost base, with material cost savings initially identified in Q4 2022 having been achieved in the business.

 

The Group's ARR increased by 34% over the 12 months to 30 June 2023 to £2.16 million (30 June 2022 ARR: £1.61 million) and by 16% since the start of the year (December 2022 ARR: £1.86 million). ARR growth has been driven by a combination of new customer wins and renewals from existing customers.

 

Bookings for the period were £1.22 million (H1 2022: £1.18 million) and revenue was £1.07 million (H1 2022: £0.91 million), representing a 3% and 18% increase on H1 2022 respectively. Deferred revenue at 30 June 2023 was £2.87 million (30 June 2022: £1.91 million).

 

The Group maintained its average contract value on the last financial year, with its partner-first sales strategy and delivering a healthy pipeline of opportunities across its Privileged Access Management ("PAM"), Privileged Process Automation ("PPA") and Endpoint Privileged Management ("EPM") solutions. All three products represent attractive standalone options to prospective customers, and have contributed meaningfully to the Group's bookings and ARR.

 

Capturing new business

 

Osirium continued its new business momentum in the new year, with 22 new customers signed by 30 June 2023.  

 

The Group's sales functions consist of a channel partner network alongside a direct sales model. The Group's channel partner network consists of over 50 active resellers and vendors across five continents.

 

In 2023, the Group has transitioned to a partner first model, with a greater emphasis placed on winning customers via the broad channel partner network. This transition positions the Group for further growth, enabling a swifter pace of customer acquisition and providing an entry point into new sectors and geographies where the Group's direct sales team is limited. A significant majority of the Group's new wins have been achieved through this model during the period alongside traditional sales and marketing such as appearances at a number of key trade shows, which raise the Group's profile among its core audiences.

 

While maintaining an emphasis on expansion within all the markets its partners operate, the Group has seen particular traction within its UK markets on account of its strong reputation and the requirements for this level of protection. New customers signed during the half include Northern Ireland Water, Quaker House, De La Rue and Telehouse.

 

Healthcare represents a core market for the Group, with Osirium counting approximately a quarter of all NHS Trusts as customers. The Group's reputation in this sector has actively contributed to the pipeline via referrals to prospective customers and direct approaches from resellers, supporting new business acquisition.

 

Customer renewals, license expansions and cross-selling

 

Alongside new customer wins, a core focus of Osirium's strategy is to achieve significant renewals, license expansions and cross-selling following an initial sale.

 

A significant number of customers bought more products or increased their license capacity during the period, aided by the continued maturation of the Group's PPA and EPM products. The Group has achieved a number of cross-sells from initial contracts, including the purchase of EPM from an initial contract, leading to the addition of the Group's PAM product. As at 30 June 2023, over 25% of active customers have been issued with licenses for more than one product.

 

In addition, supported by our customer focus and continued product enhancements, our strong rate of customer renewals has been maintained, currently at 98%.

 

Market

 

The market for privileged security has continued to grow in line with the increasing awareness of and requirement for these services globally, supporting the Group's customer acquisition.

 

Key regulatory drivers, directives and hybrid working trends continue to underpin the demand for privileged security, particularly in Europe and North America. In particular, the requirements for organisations to obtain privileged security for cyber insurance policies mean our solutions continue to be one of the factors at the top of the priority list for IT professionals.

 

Within the UK, these directives have also been issued in the Group's target sectors such as healthcare. The National Health Service's recent cyber security strategy outlines the role PAM products can play in preventing the insider threat and limiting security risks around privileged access more generally.

 

Ransomware continues to represent the core threat to IT departments, with a number of significant attacks observed during the year and reported across mainstream media. Compounded by geopolitical instability, these attacks highlight the need for privileged security in businesses and organisations of all sizes.

 

Current trading and outlook

 

The Group has made a positive start to the second half to date, with a number of further customer renewals. In addition, the Group has continued to see a growing pool of prospective new customers driven by the Group's partner network and strong reputation within its markets. Osirium's cash balance at 31 August 2023 was £89k with debtors of £242k.

 

Bridge Finance Facility

 

On 6 September 2023, Bidco (as the lender), Osirium Limited (as borrower) and the Group (as guarantor) entered into a bridge finance facility agreement (the "Bridge Finance Facility Agreement"). Pursuant to the Bridge Finance Facility Agreement, Bidco agreed to make available to Osirium Limited, as the operating subsidiary of the Group, a loan facility in an aggregate amount of up to £200,000 (the "Bridge Finance Facility"). Multiple loans may be drawn under the Bridge Finance Facility.

 

The Bridge Finance Facility is being made available to fund the working capital needs of the Group. Any drawdown is subject to the consent of Bidco, which may be granted in its sole discretion.

 

The Bridge Finance Facility will terminate on the earlier of: (i) 31 December 2023; (ii) the date falling ten Business Days (as defined in the Bridge Finance Facility Agreement, being "Bridge Finance Facility Business Days") after the date on which Bidco announces, with the consent of the Panel on Takeovers and Mergers (the "Panel"), that it does not intend to make or proceed with the Acquisition and no new, revised or replacement offer or scheme is announced in accordance with Rule 2.7 of the Takeover Code at the same time; (iii) the date falling ten Bridge Finance Facility Business Days after the date on which the Scheme is withdrawn or lapses for the purposes of the Takeover Code (save where Bidco has exercised its right to switch from the Scheme to a takeover offer prior to such withdrawal or lapse); (iv) the date falling ten Bridge Finance Facility Business Days after the date on which a third party (other than Bidco or any person acting in concert with Bidco) announces a firm intention to make an offer for shares in Osirium pursuant to Rule 2.7 of the Takeover Code, whether or not recommended, at an offer price greater than 2.35p per share; and (v) where Bidco has exercised its right to switch from the Scheme to a takeover offer, if: (a) subject to Panel consent, the offer document has not been published by 11:59 p.m. on the 28th calendar day following the announcement of such exercise of the right to switch (or such later time or date as agreed between Bidco and Osirium, with the approval of the Panel if required); or (b) such Offer lapses for the purposes of the Takeover Code, in each case on the date falling ten Bridge Finance Facility Business Days after such date.

 

Interest on each loan under the Bridge Finance Facility will accrue at a rate of 10 per cent. per annum until the date of termination of the Bridge Finance Facility Agreement. Any voluntary prepayment by Osirium Limited is without penalty or fee (apart from breakage costs and accrued interest).

 

The Bridge Finance Facility Agreement includes customary representations and undertakings and financial information rights for a facility of this kind. The Bridge Finance Facility Agreement is unsecured.

 



 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

 

 

 

 

 

 

6 months to

 

6 months to

 

Year to

 

 

 

 

 

30-Jun-23

 

30-Jun-22

 

31-Dec-22

 

 

 

 

 

(Unaudited)

 

(Unaudited)

 

(Audited)

 

 

 

 

 

£

 

£

 

£

CONTINUING OPERATIONS

 







Revenue





1,072,987


909,577


1,922,860

Other operating income





42


2


2

Administrative expenses



(2,311,136)


(2,535,240)


(5,279,002)









OPERATING LOSS

 



(1,238,109)


(1,625,661)


(3,356,140)

Finance costs




(120,067)


(107,395)


(229,701)

Finance income




3











LOSS BEFORE TAX

 



(1,358,173)


(1,733,056)


(3,585,841)

Income tax credit




228,062


315,774


640,860









LOSS FOR THE PERIOD ATTRIBUTABLE TO

 







THE OWNERS OF OSIRIUM TECHNOLOGIES PLC

 




(1,130,111)


(1,417,282)


(2,944,981)









Loss per share from continuing operations:

 







Basic and diluted loss per share





1p


5p


6p

 




 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

 

 

 

 

 

30-Jun-23

 

30-Jun-22

 

31-Dec-22

 

 

 

 

 

(Unaudited)

 

(Unaudited)

 

(Audited)

 

 

 

 

 

£

 

£

 

£

ASSETS

 









NON-CURRENT ASSETS

 









Intangible assets





3,781,195


3,721,569


3,752,102

Property, plant & equipment





41,348


68,790


54,848

Right-of-use asset





175,927


211,598


199,384






3,998,470

CURRENT ASSETS

 







Trade and other receivables





811,823


1,236,390


906,698

Cash and cash equivalents





220,443


273,218


1,081,135












1,032,266


1,509,608


1,987,833







TOTAL ASSETS

 




5,030,736


5,511,565


5,994,167

LIABILITIES

 







CURRENT LIABILITIES

 







Trade and other payables





3,379,088


2,786,811


3,307,313

Lease liability





54,609


19,125


45,216












3,433,697


2,805,936


3,352,529

NON-CURRENT LIABILITIES

 







Lease liability





167,050


212,084


194,660

Convertible loan notes





3,032,262


2,816,678


2,926,134












3,199,312


3,028,762


3,120,794







TOTAL LIABILITIES

 




6,633,009


5,834,698


6,473,323

EQUITY

 







SHAREHOLDERS EQUITY

 







Called up share capital





1,225,487


604,377


1,225,487

Share premium





13,750,312


13,006,740


13,750,312

Share option reserve





386,517


372,529


379,523

Convertible note reserve





394,830


394,830


4,008,592

Merger reserve





4,008,592


4,008,592


394,830

Retained earnings





(21,368,011)


(18,710,201)


(20,237,900)







TOTAL EQUITY ATTRIBUTABLE TO THE

 







OWNERS OF OSRIRIUM TECHNOLOGIES PLC

 




(1,602,273)


(323,133)


(479,156)









TOTAL EQUITY AND LIABILITIES

 




5,030,736


5,511,565


5,994,167


CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

 

 

 

Called up

 

Share

 

Merger

 

Share option

 

Convertible note

 

Retained

 

Total

 

 

 

Share Capital

 

premium

 

reserve

 

reserve

 

reserve

 

earnings

 

equity

 

 

 

£

 

£

 

£

 

£

 

£

 

£

 

£

Balance at 1 January 2022

 


293,820


12,462,319


4,008,592


365,535


394,830


(17,292,919)


232,176

Changes in equity

 









Total comprehensive loss








(1,417,282)


(1,417,282)

Issue of share capital



310,557


689,443






1,000,000

Issue costs




(145,021)






(145,021)

Share option charge






6,994




6,994










Balance at 30 June 2022 (unaudited)

 


604,377


13,006,741


4,008,592


372,529


394,830


(18,710,201)


(323,132)










Balance at 1 January 2022

 


293,820


12,462,319


4,008,592


365,535


394,830


(17,292,919)


232,177

Changes in equity

 









Total comprehensive loss








(2,944,981)


(2,944,981)

Issue of share capital



931,667


1,599,833






2,531,500

Issue costs




(311,840)






(311,840)

Share option charge






13,988




13,988










Balance at 31 December 2022 (audited)

 


1,225,487


13,750,312


4,008,592


379,523


394,830


(20,237,900)


(479,156)










Balance at 1 January 2023

 


1,225,487


13,750,312


4,008,592


379,523


394,830


(20,237,900)


(479,157)

Changes in equity

 









Total comprehensive loss








(1,130,111)


(1,130,111)

Share option charge






6,994




6,994










Balance at 30 June 2023 (unaudited)

 


1,225,487


13,750,312


4,008,592


386,517


394,830


(21,368,011)


(1,602,273)


CONSOLIDATED STATEMENT OF CASHFLOW

 






6 months

 

6 months

 

Year






ended

 

ended

 

ended






30-Jun-23

 

30-Jun-22

 

31-Dec-22






(unaudited)

(unaudited)

(audited)






£

 

£

 

£

Cashflows from operating activities

 









Cash used in operations





(629,067)


(602,944)


(138,715)

Tax received





640,556


603,232


603,232









Net cash from operating activities





11,489


288


464,517









Cash flows from investing activities

 







Purchase of intangible fixed assets





(853,601)


(945,808)


(1,960,912)

Purchase of tangible fixed assets





(583)


(10,524)


(15,338)

Sale of tangible fixed assets





42



Interest received





3


2










Net cash used in investing activities





(854,139)


(956,330)


(1,976,250)









Cashflows from financing activities

 







Share issue






1,000,000


2,531,500

Share issue costs






(145,021)


(311,840)

Lease payment





(25,416)


(16,947)


(25,392)

Allocation of professional fees on loan notes





7,374


7,374


14,746









Net cash (used in)/from financing activities





(18,042)


845,406


2,209,014









Increase/(decrease) in cash and cash equivalents





(860,692)


(110,636)


697,281

Cash and cash equivalents at beginning of period





1,081,135


383,854


383,854









Cash and cash equivalents at end of period





220,443


273,218


1,081,135

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GENERAL INFORMATION

 

Osirium Technologies PLC was incorporated on 3 November 2015, and registered and domiciled in England and Wales with its registered office located at One Central Square, Cardiff CF10 1FS.  

 

The principal activity of the Group in the periods under review was that of the development, sale and licensing of security software.  

 

BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES  

 

Basis of preparation

The Group financial information is presented in pounds sterling which is the Group's presentational currency, and all values are rounded to the nearest whole pound.

 

The financial information does not comprise statutory accounts within the meaning of section 435 of the Companies Act 2006. The financial information together with the comparative information for the six months ended 30 June 2022 are unaudited with the audited information included for the 12-month period ended 31 December 2022. The audited information received an audit report which was unqualified and did not include a statement under section 498(2) or section 498(3) of the Companies Act 2006 but did contain a material uncertainty paragraph on going concern.

 

The financial information was approved by the Board of Directors on 6 September 2023 and authorised for issue on 7 September 2023.  

 

Accounting Policies

The accounting policies used in the preparation of the financial information for the six months ended 30 June 2023 are in accordance with the recognition and measurement criteria of UK-adopted international accounting standards and are consistent with those which will be adopted in the annual financial statements for year ended 31 December 2023.

 

These Interim Financial Statements have been prepared in accordance with the accounting policies, methods of computation and presentation adopted in the financial statements for the year ended 31 December 2022. As permitted, the Group has chosen not to adopt IAS 34 'Interim Financial Reporting' in preparing these Interim Financial Statements.  

 

The Directors have considered all new, revised or amended standards and interpretations which are mandatory for the first time for the financial year ending 31 December 2023, and concluded that none have had any significant impact on these interim financial statements. New, revised or amended standards and interpretations that are not yet effective have not been adopted early.  

 

 

Intangible assets  

An internally generated, development intangible asset arising from Osirium's product development is recognised if, and only if, Osirium can demonstrate all of the following:

 

·      The technical feasibility of completing the intangible asset so that it will be available for use of sale.

·      Its intention to complete the intangible asset and use or sell it.

·      Its ability to use or sell the intangible asset.

·      How the intangible asset will generate probable future economic benefits.

·      The availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset.

·      Its ability to measure reliably the expenditure attributable to the intangible asset during its development.

 

Internally generated development intangible assets are amortised on a straight-line basis over their useful lives. Amortisation commences in the financial year of capitalisation. Where no internally generated intangible asset can be recognised, development expenditure is recognised as an expense in the period in which it is incurred.

 

Development costs 20% per annum, straight line.

 

Share based payments

Osirium issues equity-settled share-based payments to certain employees and others under which Osirium receives services as consideration for equity instruments (options) in Osirium. Equity-settled share-based payments are measured at fair value at the date of grant by reference to the fair value of the equity instruments granted. The fair value determined at the grant date of equity-settled share-based payments is recognised as an expense in Osirium's Statement of Comprehensive Income over the vesting period on a straight-line basis, based on Osirium's estimate of the number instruments that will eventually vest with a corresponding adjustment to equity. The expected life used in the valuation is adjusted, based on management's best estimate, for the effect of non-transferability, exercise restrictions, and behavioural considerations.

 

Non-vesting and market vesting conditions are taken into account when estimating the fair value of the options at grant date. Service and non-market vesting conditions are taken into account by adjusting the number of options expected to vest at each reporting date. When the options are exercised Osirium issues new shares. The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium.

 



 

INTANGIBLE FIXED ASSETS

 

 

 

 

 

 

Development

 

 

 

 

 

Costs

 

 

 

 

 

£

Cost

 





At 1 January 2022

 




11,349,999

Additions to 30 June 2022





945,808

Cost c/f as at 30 June 2022





12,295,807







At 1 January 2022

 




11,349,999

Additions to 31 December 2022





1,960,912

Cost c/f as at 31 December 2022





13,310,911







At 1 January 2023

 




13,310,911

Additions to 30 June 2023





853,601

Cost c/f as at 30 June 2023





14,164,512







Amortisation

 





At 1 January 2022

 




7,792,689

Charge to 30 June 2022





781,549

Amortisation c/f as at 30 June 2022





8,574,238







At 1 January 2022

 




7,792,689

Charge to 31 December 2022





1,766,120

Amortisation c/f as at 31 December 2022





9,558,809







At 1 January 2023

 




9,558,809

Charge to 30 June 2023





824,508

Amortisation c/f as at 30 June 2023





10,383,317







Carrying Amount:

 











At 30 June 2022 (unaudited)





3,721,569







At 31 December 2022 (unaudited)





3,752,102







At 30 June 2023 (unaudited)





3,781,195

 

 All development costs are amortised over their estimated useful lives, which is on average 5 years. Amortisation is charged in full in the financial year of capitalisation.

 

All amortisation has been charged to administrative expenses in the statement of comprehensive income.

RIGHT OF USE ASSETS

 

 

 

 

 

Leases & Buildings

 

 

 

 

£

Cost

 




At 31 December 2021




159,455

Additions




234,569

Disposals




(159,455)

At 31 December 2022




234,569

Additions




At 30 June 2023




234,569






Depreciation

 




At 31 December 2021




147,189

Charge for year




47,451

Depreciation eliminated on disposal




(159,455)

At 31 December 2022




35,185

Charge for year




23,457

At 30 June 2023




58,642






Net Book Value

 




At 31 December 2022




199,384






At 30 June 2023




175,927

 

 Additions to the right of use assets during the period were £nil (year to 31 December 2022: £234,569).

 

The group leases land and buildings for its office under an agreement for 5 years running from 2022 to 2027.

 

LEASE LIABILITIES

 

 

 

 

As at

 

As at

 

As at

 

 

 

30-Jun-23

 

30-Jun-22

 

31-Dec-22

 

 

 

£

 

 

£

Current

 





Lease liability



54,609


19,125


45,216







Non- current

 





Lease liability



167,050


212,084


194,660

 

 

 



 

RECONCILIATION OF LOSS BEFORE INCOME TAX TO CASH FROM OPERATIONS

 

 

 

 

 

 

 

6 months

 

6 months

 

Year

 

 

 

 

 

ended

 

ended

 

ended

 

 

 

 

 

30-Jun-23

 

30-Jun-22

 

31-Dec-22

 

 

 

 

 

(unaudited)

(unaudited)

(audited)

 

 

 

 

 

£

 

£

 

£

Loss before income tax





(1,358,173)


(1,733,056)


(3,585,841)

Depreciation charges





37,541


44,729


75,265

Amortisation charges





824,508


781,549


1,766,120

Share option charge





6,994


6,994


13,988

Profit on disposal of fixed assets





(42)



Finance costs





105,853


107,395


229,701

Finance income





(3)
















(383,322)


(792,388)


(1,500,767)

(Increase)/decrease in trade and other receivables





(317,522)


(22,036)


213,190

Increase /(decrease) in trade and other payables





71,777


211,480


1,148,862









Cash used in operations





(629,067)


(602,944)


(138,715)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DQLFBXKLBBBV